MANILA, Philippines — The Food and Drug Administration may come up with its evaluation on the clinical trial proposal for China’s COVID-19 vaccine Sinovac within two weeks, FDA Director General Eric Domingo said Friday. “Sabay na natin ginagawa ‘yung mga ethics committee plus ‘yung technical and administrative regulatory evaluation ng FDA,” he said in an online media forum. ADVERTISEMENT(The ethics committee review and the administrative regulatory evaluation of the FDA is being simultaneously done.) Earlier this month, it submitted to FDA its application to conduct Phase 3 of clinical trials of its COVID-19 vaccine in the country. Domingo said Sinovac could only start its clinical trials once the FDA regulatory review and the ethics committee board have approved it.

Source: Philippine Daily Inquirer October 30, 2020 07:17 UTC